Press Releases
  Date Title View
Mar 18, 2010
WALTHAM, Mass., Mar 18, 2010 (BUSINESS WIRE) -- ImmunoGen, Inc. (Nasdaq: IMGN) is scheduled to present at the 2010 Barclays Capital Global Healthcare Conference at 3:45 pm ET on March 24, 2010. The Conference is being held at the Loews Miami Beach Hotel in Miami Beach, Florida. ImmunoGen's presentation wil...
PDF
Mar 8, 2010
WALTHAM, Mass., Mar 08, 2010 (BUSINESS WIRE) -- ImmunoGen, Inc. (Nasdaq: IMGN), a biotechnology company that develops targeted anticancer products using its antibody expertise and Targeted Antibody Payload (TAP) technology, today announced that the US Food and Drug Administration (FDA) has granted orphan drug designation to its IMGN901 compound ...
PDF
Mar 1, 2010
WALTHAM, Mass., Mar 01, 2010 (BUSINESS WIRE) -- ImmunoGen, Inc. (Nasdaq: IMGN) announced today that management will participate in two upcoming investor conferences with live webcasts. RBC Capital Markets Healthcare Conference, New York Palace Hotel, New York, NY Gregory Perry, Senior Vice President and Chief Financial Office...
PDF
Feb 3, 2010
WALTHAM, Mass., Feb 03, 2010 (BUSINESS WIRE) -- ImmunoGen, Inc. (Nasdaq: IMGN), a biopharmaceuticals company that develops targeted anticancer therapeutics using its Targeted Antibody Payload (TAP) technology, invites investors, journalists and the general public to listen to a live webcast of the Company's investment community meeting on Februa...
PDF
Feb 2, 2010
WALTHAM, Mass., Feb 02, 2010 (BUSINESS WIRE) -- ImmunoGen, Inc. (Nasdaq: IMGN) is scheduled to present at the 12th Annual BIO CEO & Investor Conference at 2:30 pm ET on February 9, 2010. The Conference is being held at the Waldorf=Astoria hotel in New York City. ImmunoGen's presentation will be webcast...
PDF
Jan 28, 2010
WALTHAM, Mass., Jan 28, 2010 (BUSINESS WIRE) -- ImmunoGen, Inc. (Nasdaq: IMGN), a biotechnology company that develops targeted anticancer products using its antibody expertise and Targeted Antibody Payload (TAP) technology, today announced financial results for the three-month period ended December 31, 2009 - the ...
PDF
Jan 21, 2010
WALTHAM, Mass., Jan 21, 2010 (BUSINESS WIRE) -- ImmunoGen, Inc. (Nasdaq: IMGN), a biotechnology company that develops targeted anticancer products, today announced that will host a conference call at 4:30 p.m. ET on Thursday, January 28, 2010 to discuss the Company's financial results for the three-month period ended December 31, 2009 - the seco...
PDF
Jan 6, 2010
WALTHAM, Mass., Jan 06, 2010 (BUSINESS WIRE) -- ImmunoGen, Inc. (Nasdaq: IMGN) is scheduled to present at the 28th Annual J.P. Morgan Healthcare Conference at 9:30 am PST on January 14, 2010. The Conference is being held at the Westin St. Francis hotel in San Francisco, CA. ImmunoGen's presentation will be webcast live and can be accessed throug...
PDF
FirstPrevious ...
14

You are now leaving this website. If you would like to continue, click Continue.
CancelContinue